NCT03308110View on ClinicalTrials.gov

Bioavailability and Food Effect Study of Two Formulations of PF-06650833

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

December 8, 2017

Study Completion Date

January 11, 2018

Conditions
Healthy
Interventions
DRUG

PF-06650833

Two formulations of PF-006650833

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 | Biotech Hunter | Biotech Hunter